Could a gentle zap protect older hearts from hidden lung threat after surgery?
NCT ID NCT07710001
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This study tests whether a device that delivers gentle electrical stimulation to the neck can prevent silent aspiration — when fluid or food enters the airway without causing coughing — in patients aged 60 and older after heart valve surgery. Researchers measure two substances in airway secretions as markers of aspiration. The goal is to see if this non-invasive intervention is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Gentle Stim Electrical Stimulation Therapy Device (Model: JC-2071)
- What this could lead to
- If effective, this approach could reduce the risk of silent aspiration and related complications in elderly patients recovering from heart valve surgery.
- What could go wrong
- This is a small, early-stage study focused on biomarker outcomes, so results may not confirm clinical benefit. The device may not prevent aspiration in all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
117 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Simple valve surgery * Age ≥60 years old * NYHA cardiac function Grade II-III * ASA Grade II-III * No dysphagia screened by SSA before surgery Exclusion Criteria: * Vocal cord dysfunction, oropharyngeal malignancies, or neck surgery affecting swallowing function * Postoperative hemodynamic instability and active bleeding * COPD, asthma, chronic bronchitis, lung cancer or other respiratory diseases * Previous gastroesophageal reflux disease * Serious mental or neurological disease * Skin damage or electrode allergy at the stimulation site * Implanted cardiac pacemaker * Participation in other interventional studies
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Elderly heart valve surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.